IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fairmount Funds Management LLC

Q3 2022 Holdings

Filed 2022-11-09 | 27 holdings | $228.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axsome Therapeutics Inc(AXSM)COM05464T104$84.6M1,896,64737.0%
Cogent Biosciences Inc(COGT)COM19240Q201$41.2M2,758,97518.0%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$32.0M2,543,10714.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$26.0M73,52611.3%
Annexon Inc(ANNX)COM03589W102$20.8M3,358,5639.1%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$12.3M751,8045.4%
Beigene LTD(ONC)SPONSORED ADR07725L102$11.6M86,4005.1%
Nuvalent Inc(NUVL)COM670703107$40.4K2,079,8630.0%
Biohaven Pharmactl Hldg Co(BHVN)COMG11196105$31.0K204,7430.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$30.1K283,0000.0%
Insmed Inc(INSM)COM PAR $.01457669307$28.8K1,336,3680.0%
Viridian Therapeutics Inc(VRDN)COM92790C104$28.1K1,369,6230.0%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$27.4K2,678,9820.0%
Axsome Therapeutics IncCallCOM05464T904$26.8K600,0000.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$24.3K469,2640.0%
Point Biopharma Global IncCOM730541109$21.9K2,833,9500.0%
DBV Technologies SASPONSORED ADR23306J101$12.5K7,064,9640.0%
Tyra Biosciences Inc(TYRA)COM90240B106$12.5K1,416,9980.0%
Terns Pharmaceuticals Inc(TERN)COM880881107$12.1K2,050,0000.0%
Keros Therapeutics Inc(KROS)COM492327101$10.3K272,4980.0%
Trevi Therapeutics Inc(TRVI)COM89532M101$8.8K5,696,5150.0%
Astria Therapeutics Inc(CATBUSD)COM04635X102$8.2K911,7360.0%
Amarin Corp PLCSPONS ADR NEW023111206$6.1K5,584,8370.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$3.7K389,5880.0%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$3.4K1,231,5660.0%
Instil BIO IncCOM45783C101$3.3K673,9050.0%
Allakos Inc(ALLKGUSD)COM01671P100$901147,1890.0%